2009 Biotechnology Vision Summit
Wednesday, October 7, 2009
Madison Marriott West
Middleton WI
2009 Program - click here to view
Industry Speakers
Click here to view the conference flyer and just announced speakers, including:
Thomas J. Albert, Ph.D.; Sr Director, Array Technologies; Roche Nimblegen
Robert F. Carey; Managing Director and Co-Head of Healthcare Investment Banking; JMP Securities
Bill Clarke, M.D., M.Sc.; President and CEO; Cellectar
Kevin T. Conroy; President and CEO; Exact Sciences
Gregg Fergus; President and COO; Ion Torrent Systems
T. Randall Fortenbery, Ph.D.; Professor Agricultural and Applied Economics; UW Madison
Andrew Held; Director, Process Engineering; Virent
Henry Hummel; VP and General Manager; Covance Laboratories Inc.
Chris Kendrick-Parker; VPand Chief Commercial Officer; CDI
Mark Kramer; VP Regulatory Affairs; GE Healthcare
Barry Kurokawa; Founder and Managing Partner; ProMed Advisors, LLC
John Neis; Managing Director; Venture Investors
David Parker, Ph.D.; Vice President; Boston Healthcare
Brian Scanlan; VP of Corporate Development; Cambridge Major Laboratories Inc.
P. Schaefer Price; President and CEO; Pharmasset
Randall W. Shultz, Ph.D.; Team Lead-Dicot Gene Expression Technology; Monsanto
Mark P. Stevenson; President and Chief Operating Officer; Life Technologies
Michael Wasserman; HIG BioVentures
Exhibit and Sponsorship:
For information about sponsorship and exhibition opportunities, click here.
Program Highlights:
|
√ Plenary sessions convened by industry leaders and focused on how to craft strategies for success in the face of a challenging environment |
√ Exhibit Hall with over 40 participants | |
| √ Concurrent Sessions on drug and diagnostic development, life science tools and bioagriculature |
√ Collaboration Corner to provide you a setting to meet with industry colleagues |
|
| √ Emerging Companies Showcase |
√ Luncheon Plenary /"What is State Government Doing to Foster Innovation?" |
|
| √ Closing Reception |






